ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,306.18
0.37%
Dow Jones
38,686.32
0.00%
Gold vs US Dollar
2,333.235
0.25%
Brent Oil
80.84
0.04%
Bitcoin
69,635.42
2.79%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cumberland Pharmaceutical Inc (CPIX)

  7. Cumberland Pharmaceutical Inc (CPIX) News

Cumberland Pharmaceutical (CPIX)

Cumberland Pharmaceutical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CPIX
DateTimeSourceHeadlineSymbolCompany
10/05/202421:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CPIXCumberland Pharmaceutical Inc
10/05/202421:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202422:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202421:05PR Newswire (US)Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company UpdateNASDAQ:CPIXCumberland Pharmaceutical Inc
30/04/202421:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
02/04/202421:05PR Newswire (US)NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONSNASDAQ:CPIXCumberland Pharmaceutical Inc
05/03/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
05/03/202421:05PR Newswire (US)Cumberland Pharmaceuticals Reports Annual 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
27/02/202421:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
09/02/202422:27Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CPIXCumberland Pharmaceutical Inc
28/12/202322:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
28/12/202322:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
28/12/202322:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
27/12/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CPIXCumberland Pharmaceutical Inc
15/12/202321:14Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:CPIXCumberland Pharmaceutical Inc
14/12/202322:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202322:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202322:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202322:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202322:01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CPIXCumberland Pharmaceutical Inc
17/11/202322:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
07/11/202322:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
07/11/202321:05PR Newswire (US)Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
03/11/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
03/11/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
03/11/202321:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
31/10/202320:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
17/10/202322:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
13/10/202314:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
10/10/202321:05PR Newswire (US)NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGENASDAQ:CPIXCumberland Pharmaceutical Inc
 Showing the most relevant articles for your search:NASDAQ:CPIX

Your Recent History

LSE
SYME
Supply@me Capital
LSE
POS
Plexus
LSE
CHLL
Chill Brands
LSE
ITM
Itm Power
LSE
EEE
Empire Metals
LSE
BP.
Bp
LSE
HVO
Hvivo
LSE
RKH
Rockhopper Exploration
LSE
GDR
Genedrive
LSE
VAST
Vast Resources
LSE
UJO
Union Jack Oil
LSE
GSK
Gsk
LSE
KEFI
Kefi Gold And Copper
LSE
AAZ
Anglo Asian Mining
LSE
BIRD
Blackbird
LSE
SAR
Sareum
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved